跳至主要内容
临床试验/IRCT2017071935183N1
IRCT2017071935183N1已完成未知

Comparing the effect of receiving only bolus dose Eptifibatide with bolus plus infusion strategy on bleeding complications and consequences after Percutaneous Coronary Intervention (PCI) on Myocardial Infarct (MI) patients

isfahan university of medical science0 个研究点目标入组 176 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
176

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 90 years(—)
性别
All

入选标准

  • Inclusion criteria were as followed: 1) age more than 18 years, 2)having elevation in Troponin enzyme level, 3) having electrocardiogram changes due to infarction, 4)candidate for angioplasty and percutaneous coronary intervention, 5) having no contraindication for administrating Eptifibatide, 6) patient's willingness to participate in this study
  • Exclusion criteria were as followed:1) Patient's unwillingness to continue his/ her participation, 2)history of stroke, 3)treating with anti coagulant medications, 4)using medications that has interaction with Eptifibatide, 5) have not experience PCI, 6)have experienced thrombectomy, 7) having sensitivity to Eptifibatide, 8) having uncontrolled hypertension, 9) dialysis patients

排除标准

  • 未提供

研究者

发起方
isfahan university of medical science

相似试验